Mitochondrial haplogroups and cognitive progression in Parkinson's disease

Archive ouverte

Liu, Ganqiang | Ni, Chunming | Zhan, Jiamin | Li, Weimin | Luo, Junfeng | Liao, Zhixiang | Locascio, Joseph J. | Xian, Wenbiao | Chen, Ling | Pei, Zhong | Corvol, Jean Christophe | Maple-Grødem, Jodi | Campbell, Meghan C. | Elbaz, Alexis | Lesage, Suzanne | Brice, Alexis | Hung, Albert Y. | Schwarzschild, Michael A. | Hayes, Michael T. | Wills, Anne Marie A. | Ravina, Bernard | Shoulson, Ira | Taba, Pille | Kõks, Sulev | Beach, Thomas Gerald | Cormier-Dequaire, Florence | Alves, Guido | Tysnes, Ole Bj̈orn | Perlmutter, Joel S. | Heutink, Peter | van Hilten, Jacobus Johannes Bob | Barker, Roger A. | Williams-Gray, Caroline H. | Scherzer, Clemens R.

Edité par CCSD ; Oxford University Press -

International audience. Mitochondria are a culprit in the onset of Parkinson's disease, but their role during disease progression is unclear. Here we used Cox proportional hazards models to exam the effect of variation in the mitochondrial genome on longitudinal cognitive and motor progression over time in 4064 patients with Parkinson's disease. Mitochondrial macro-haplogroup was associated with reduced risk of cognitive disease progression in the discovery and replication population. In the combined analysis, patients with the super macro-haplogroup J, T, U# had a 41% lower risk of cognitive progression with P = 2.42 × 10-6 compared to those with macro-haplogroup H. Exploratory analysis indicated that the common mitochondrial DNA variant, m.2706A>G, was associated with slower cognitive decline with a hazard ratio of 0.68 (95% confidence interval 0.56-0.81) and P = 2.46 × 10-5. Mitochondrial haplogroups were not appreciably linked to motor progression. This initial genetic survival study of the mitochondrial genome suggests that mitochondrial haplogroups may be associated with the pace of cognitive progression in Parkinson's disease over time.

Suggestions

Du même auteur

Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease

Archive ouverte | Liu, Ganqiang | CCSD

International audience. A key driver of patients' well-being and clinical trials for Parkinson's disease (PD) is the course that the disease takes over time (progression and prognosis). To assess how genetic variati...

Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts

Archive ouverte | Liu, Ganqiang | CCSD

International audience. Summary Background Cognitive decline is a debilitating manifestation of disease progression in Parkinson’s disease. We aimed to develop a clinical-genetic score to predict global cognitive im...

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

Archive ouverte | Iwaki, Hirotaka | CCSD

International audience. Abstract Background Several reports have identified different patterns of Parkinson's disease progression in individuals carrying missense variants in GBA or LRRK2 genes. The overall contribu...

Chargement des enrichissements...